The Filings Report

Becton, Dickinson and Co. insider trading

BDXfinancial statementsForm 4 filings on EDGAR157 transactions since Nov 1, 2024

From August 4, 2026 to November 1, 2026, 0 insiders at Becton, Dickinson and Co. bought $0 of stock in the open market, and 3 sold $1M. Officers and directors accounted for $0 of purchases and $1M of sales. The last reported transaction was an open-market sale by Feld Michael on October 26, 2026.

The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through October 27, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.

Stock price and insider activity

Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.

BDX daily priceSplit-adjusted prices in US dollars

Bought $0Sold $1MAug 4, 2026 – Nov 1, 2026

Oct 30, 2026O $199.77 · H $199.94 · L $197.06 · C $197.88Bought $0 (0)Sold $0 (0)
$165$174$184$193$2022026-08-04: open $168.00, high $170.76, low $166.80, close $170.122026-08-05: open $169.73, high $170.91, low $168.01, close $170.662026-08-06: open $175.88, high $179.40, low $172.76, close $177.072026-08-07: open $175.26, high $177.55, low $173.29, close $176.862026-08-10: open $176.49, high $179.79, low $175.63, close $179.632026-08-11: open $178.35, high $181.79, low $178.35, close $181.412026-08-12: open $177.61, high $183.75, low $177.13, close $183.582026-08-13: open $184.75, high $185.32, low $181.41, close $181.972026-08-14: open $182.12, high $183.82, low $181.22, close $183.402026-08-17: open $181.89, high $183.46, low $181.62, close $182.092026-08-18: open $184.94, high $185.80, low $180.72, close $180.772026-08-19: open $183.71, high $187.96, low $181.52, close $187.602026-08-20: open $186.20, high $190.01, low $185.36, close $187.622026-08-21: open $188.02, high $192.30, low $186.95, close $192.002026-08-24: open $191.73, high $193.07, low $190.35, close $190.742026-08-25: open $189.31, high $190.07, low $187.03, close $189.782026-08-26: open $188.49, high $191.52, low $188.02, close $190.212026-08-27: open $189.29, high $190.41, low $187.73, close $188.132026-08-28: open $188.04, high $190.32, low $187.54, close $189.522026-08-31: open $187.88, high $188.97, low $186.62, close $188.112026-09-01: open $190.30, high $191.57, low $186.48, close $187.122026-09-02: open $187.43, high $191.76, low $187.43, close $187.522026-09-03: open $188.97, high $189.47, low $184.91, close $187.622026-09-04: open $185.42, high $187.13, low $184.05, close $184.742026-09-08: open $181.75, high $182.20, low $178.47, close $179.102026-09-09: open $177.15, high $182.10, low $176.55, close $179.802026-09-10: open $178.94, high $178.94, low $175.67, close $176.422026-09-11: open $177.60, high $178.30, low $175.20, close $177.852026-09-14: open $180.05, high $183.53, low $179.60, close $182.912026-09-15: open $182.39, high $186.63, low $181.28, close $185.922026-09-16: open $185.18, high $186.27, low $181.29, close $181.852026-09-17: open $182.71, high $184.34, low $181.27, close $181.382026-09-18: open $179.76, high $182.62, low $179.42, close $180.942026-09-21: open $181.25, high $181.53, low $179.98, close $180.702026-09-22: open $182.40, high $183.83, low $180.75, close $183.002026-09-23: open $182.10, high $184.37, low $181.31, close $182.522026-09-24: open $182.73, high $183.72, low $178.98, close $179.232026-09-25: open $179.22, high $183.92, low $177.87, close $183.822026-09-28: open $183.07, high $184.34, low $181.95, close $183.832026-09-29: open $182.51, high $182.95, low $180.09, close $181.972026-09-30: open $181.19, high $182.34, low $178.91, close $179.002026-10-01: open $179.11, high $179.67, low $177.02, close $178.072026-10-02: open $177.46, high $178.13, low $175.71, close $176.802026-10-05: open $176.58, high $180.90, low $176.04, close $180.672026-10-06: open $183.35, high $187.45, low $180.12, close $180.302026-10-07: open $180.34, high $182.38, low $177.92, close $180.162026-10-08: open $179.76, high $182.76, low $178.90, close $182.752026-10-09: open $181.89, high $183.85, low $181.51, close $183.752026-10-12: open $184.32, high $188.92, low $184.32, close $188.892026-10-13: open $189.82, high $189.99, low $185.59, close $187.372026-10-14: open $188.26, high $189.68, low $186.04, close $188.892026-10-15: open $192.00, high $194.34, low $190.95, close $193.762026-10-16: open $194.42, high $195.99, low $190.21, close $191.752026-10-19: open $190.10, high $191.86, low $189.49, close $190.742026-10-20: open $192.78, high $193.85, low $191.35, close $193.802026-10-21: open $191.72, high $195.22, low $191.72, close $194.342026-10-22: open $195.35, high $200.47, low $194.91, close $200.422026-10-23: open $199.18, high $200.42, low $197.15, close $198.912026-10-26: open $198.13, high $198.90, low $194.71, close $196.392026-10-27: open $194.77, high $196.16, low $194.10, close $195.032026-10-28: open $194.22, high $196.88, low $193.80, close $195.162026-10-29: open $197.11, high $198.64, low $194.53, close $198.342026-10-30: open $199.77, high $199.94, low $197.06, close $197.88Insider purchases / sales · USD$1M$0−$1M2026-08-11: 0 purchases ($0), 1 sales ($441K)2026-08-13: 0 purchases ($0), 1 sales ($768K)2026-08-26: 0 purchases ($0), 1 sales ($31K)2026-09-28: 0 purchases ($0), 1 sales ($14K)2026-10-26: 0 purchases ($0), 1 sales ($15K)Aug 4Aug 26Sep 17Oct 9Oct 30

purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.

Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.

Every transaction

157 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 26, 2026Feld MichaelEVP, Chief Revenue Officeropen-market sale10b5-176$198.13$15K19,568Oct 27, 2026
Sep 28, 2026Feld MichaelEVP, Chief Revenue Officeropen-market sale10b5-176$183.70$14K19,644Sep 29, 2026
Sep 2, 2026Roque VitorEVP & Chief Financial Officertax withholding190$0.00—8,041Sep 3, 2026
Aug 26, 2026Feld MichaelEVP, Chief Revenue Officeropen-market sale10b5-1165$188.49$31K19,720Aug 27, 2026
Aug 20, 2026Feld MichaelEVP, Chief Revenue Officertax withholding1,049$0.00—19,885Aug 24, 2026
Aug 13, 2026Polen Thomas E JrChairman, CEO and President, Directoroption exercise43,278$167.25$7M153,441Aug 14, 2026
Aug 13, 2026Polen Thomas E JrChairman, CEO and President, Directordisposition to issuer39,126$185.00$7M114,315Aug 14, 2026
Aug 13, 2026Polen Thomas E JrChairman, CEO and President, Directoropen-market sale10b5-14,152$185.00$768K110,163Aug 14, 2026
Aug 11, 2026Goette RolandEVP and President, EMEAopen-market sale2,438$180.84$441K14,856Aug 12, 2026
Jul 27, 2026Feld MichaelEVP, Chief Revenue Officeropen-market sale10b5-175$157.13$12K20,934Jul 28, 2026
Jul 2, 2026Muhsin BilalEVP & President Connected Caretax withholding1,935$0.00—41,359Jul 6, 2026
Jul 1, 2026Muhsin BilalEVP & President Connected Careaward14,342$0.00—43,294Jul 6, 2026
Jun 26, 2026Feld MichaelEVP, Chief Revenue Officeropen-market sale10b5-175$152.80$11K21,009Jun 26, 2026
Jun 24, 2026Garrison Michael DavidEVP & Pres Med.Essntl&BioPharmopen-market sale10b5-11,100$145.66$160K13,172Jun 25, 2026
Jun 10, 2026Garrison Michael DavidEVP & Pres Med.Essntl&BioPharmopen-market sale10b5-11,100$151.48$167K14,272Jun 11, 2026
Jun 1, 2026Polen Thomas E JrChairman, CEO and President, Directoroption exercise20,209$126.16$3M125,680Jun 3, 2026
Jun 1, 2026Polen Thomas E JrChairman, CEO and President, Directordisposition to issuer17,445$146.15$3M108,235Jun 3, 2026
Jun 1, 2026Polen Thomas E JrChairman, CEO and President, Directoropen-market sale10b5-12,764$146.35$405K110,163Jun 3, 2026
Jun 1, 2026Menziuso PeterEVP and President, BDIaward14,258$0.00—14,258Jun 2, 2026
May 26, 2026Feld MichaelEVP, Chief Revenue Officeropen-market sale10b5-175$147.35$11K21,084May 27, 2026
May 7, 2026Roque VitorEVP & Chief Financial Officeraward1,721$0.00—8,231May 8, 2026
Apr 27, 2026Feld MichaelEVP, Chief Revenue Officeropen-market sale10b5-174$151.94$11K21,159Apr 28, 2026
Apr 6, 2026Neal Shana CarolEVP and Chief People Officertax withholding1,146$0.00—23,966Apr 6, 2026
Mar 26, 2026Feld MichaelEVP, Chief Revenue Officeropen-market sale10b5-175$156.83$12K21,233Mar 27, 2026
Mar 16, 2026Minnix LaneshaEVP and General Counselaward7,492$0.00—7,492Mar 17, 2026
Mar 2, 2026Roque VitorInterim CFOaward931$0.00—6,510Mar 4, 2026
Mar 2, 2026Spikner Pamela L.SVP Controller & CAOaward931$0.00—3,323Mar 4, 2026
Feb 26, 2026Feld MichaelEVP, Chief Revenue Officeropen-market sale10b5-175$181.84$14K21,308Feb 27, 2026
Feb 18, 2026Scott Bertram LDirectoropen-market sale953$182.61$174K36,763Feb 18, 2026
Jan 27, 2026Henderson Jeffrey WilliamDirectoraward1,098$0.00—9,143Jan 29, 2026
Jan 27, 2026Eckert R AndrewDirectoraward1,098$0.00—10,423Jan 29, 2026
Jan 27, 2026Byington Carrie LDirectoraward1,098$0.00—5,018Jan 29, 2026
Jan 27, 2026Hayes GregoryDirectoraward1,098$0.00—7,159Jan 29, 2026
Jan 27, 2026Brown William MDirectoraward1,098$0.00—4,663Jan 29, 2026
Jan 27, 2026Huffines Robert LutherDirectoraward1,098$0.00—1,279Jan 29, 2026
Jan 27, 2026Jones Christopher Ian MontagueDirectoraward1,098$0.00—24,304Jan 29, 2026
Jan 27, 2026Ring Timothy MDirectoraward1,098$0.00—59,160Jan 29, 2026
Jan 27, 2026Scott Bertram LDirectoraward1,098$0.00—37,716Jan 29, 2026
Jan 27, 2026Waldstreicher JoanneDirectoraward1,098$0.00—3,391Jan 29, 2026
Jan 27, 2026Wright JacquelineDirectoraward1,098$0.00—1,279Jan 29, 2026
Jan 26, 2026Feld MichaelEVP, CRO & Pres. Life Sciencesopen-market sale10b5-175$202.73$15K16,431Jan 28, 2026
Jan 21, 2026Spikner Pamela L.SVP Controller & CAOtax withholding84$0.00—1,832Jan 23, 2026
Jan 15, 2026Garrison Michael DavidEVP & Pres Med.Essntl&BioPharmopen-market sale10b5-11,010$206.54$209K12,095Jan 16, 2026
Jan 15, 2026Garrison Michael DavidEVP & Pres Med.Essntl&BioPharmopen-market sale10b5-1600$209.00$125K13,105Jan 16, 2026
Jan 15, 2026Garrison Michael DavidEVP & Pres Med.Essntl&BioPharmoption exercise3,054$167.91$513K16,159Jan 16, 2026
Jan 15, 2026Garrison Michael DavidEVP & Pres Med.Essntl&BioPharmdisposition to issuer2,454$209.00$513K13,705Jan 16, 2026
Jan 3, 2026Shan DavidEVP and Chief ISC Officertax withholding44$0.00—8,926Jan 6, 2026
Dec 26, 2025Feld MichaelEVP, CRO & Pres. Life Sciencesopen-market sale10b5-174$196.08$15K16,506Dec 29, 2025
Dec 17, 2025Garrison Michael DavidEVP & Pres Med.Essntl&BioPharmopen-market sale10b5-1629$196.03$123K13,105Dec 17, 2025
Dec 1, 2025Feld MichaelEVP, CRO & Pres. Life Sciencesopen-market sale10b5-175$193.36$15K16,580Dec 2, 2025

Who the insiders are

Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.

InsiderRoleLast transactionKindShares heldBought, 12 monthsSold, 12 monthsSales under a plan
Polen Thomas E JrChairman, CEO and President, DirectorAug 13, 2026option exercise153,441—$1M (2)2 of 2
Garrison Michael DavidEVP & Pres Med.Essntl&BioPharmJun 24, 2026open-market sale13,172—$784K (5)5 of 5
Goette RolandEVP and President, EMEAAug 11, 2026open-market sale14,856—$441K (1)0 of 1
Scott Bertram LDirectorFeb 18, 2026open-market sale36,763—$212K (2)0 of 2
Feld MichaelEVP, Chief Revenue OfficerOct 26, 2026open-market sale19,568—$175K (12)12 of 12
Neal Shana CarolEVP and Chief People OfficerApr 6, 2026tax withholding23,966———
Shan DavidEVP and Chief ISC OfficerJan 3, 2026tax withholding8,926———
Byrd RichardEVP & President InterventionalNov 26, 2025tax withholding13,849———
Mocherla Pavan KumarEVP & President, Greater AsiaNov 26, 2025award5,763———
DelOrefice ChristopherEVP & Chief Financial OfficerNov 26, 2025tax withholding22,982———
Muhsin BilalEVP & President Connected CareJul 2, 2026tax withholding41,359———
Roque VitorEVP & Chief Financial OfficerSep 2, 2026tax withholding8,041———
Spikner Pamela L.SVP Controller & CAOMar 2, 2026award3,323———
Henderson Jeffrey WilliamDirectorJan 27, 2026award9,143———
Hayes GregoryDirectorJan 27, 2026award7,159———
Fraser ClaireDirectorSep 10, 2025open-market sale22,226———
Quinn MichelleEVP and General CounselNov 26, 2024tax withholding6,927———
Ezell Antoine CEVP, President Americas & CMONov 26, 2024tax withholding11,970———
Eckert R AndrewDirectorJan 27, 2026award10,423———
Byington Carrie LDirectorJan 27, 2026award5,018———
Brown William MDirectorJan 27, 2026award4,663———
Huffines Robert LutherDirectorJan 27, 2026award1,279———
Jones Christopher Ian MontagueDirectorJan 27, 2026award24,304———
Ring Timothy MDirectorJan 27, 2026award59,160———
Waldstreicher JoanneDirectorJan 27, 2026award3,391———
Wright JacquelineDirectorJan 27, 2026award1,279———
Menziuso PeterEVP and President, BDIJun 1, 2026award14,258———
Minnix LaneshaEVP and General CounselMar 16, 2026award7,492———
Burzik Catherine MDirectorJan 28, 2025award14,264———

Questions

Are Becton, Dickinson and Co. insiders buying or selling?

Over the twelve months to November 1, 2026, 5 insiders at Becton, Dickinson and Co. sold $3M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $3M. Only open-market purchases and sales are counted.

Who sold the most Becton, Dickinson and Co. stock in the last year?

Polen Thomas E Jr (Chairman, CEO and President, Director) sold $1M in 2 open-market sales over the twelve months to November 1, 2026.

Do Becton, Dickinson and Co. executives sell under 10b5-1 plans?

19 of the 22 open-market sales in the last twelve months (86%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.

What counts as insider buying here?

Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.

More on Becton, Dickinson and Co.

From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.